Patents matching “treatment”

US 6350785

Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Maxim Pharmaceuticals, Inc. · Granted Feb 26, 2002 · Expires Feb 21, 2022

US 6347633

Treatment of hepatitis C using hyperthermia

First Circle Medical, Inc. · Granted Feb 19, 2002 · Expires Feb 14, 2022

US 6348493

Treatment and prevention of hepatic disorders

The Regents of the University of California · Granted Feb 19, 2002 · Expires Feb 14, 2022

US 6344195

Reovirus for the treatment of neoplasia

ONCOLYTICS BIOTECH INC. · Granted Feb 5, 2002 · Expires Jan 31, 2022

GR 3036905

VETERINARY TREATMENT.

BEECHAM GROUP PLC [GB] · Granted Jan 31, 2002 · Expires Jan 26, 2022

US 6342529

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Jan 29, 2002 · Expires Jan 24, 2022

US 6342484

Method and compositions for promotion of wound treatment

The Board of Regents of the University of Texas System · Granted Jan 29, 2002 · Expires Jan 24, 2022

US 6331555

Treatment of platelet derived growth factor related disorders such as cancers

The Regents of the University of California · Granted Dec 18, 2001 · Expires Dec 13, 2021

US 6329357

Therapeutically effective 1.alpha., 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases

The Regents of the University of California · Granted Dec 11, 2001 · Expires Dec 6, 2021

US 6329499

Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein

Neurocrine Biosciences, Inc. · Granted Dec 11, 2001 · Expires Dec 6, 2021

US 6329403

Pharmaceutical composition for the treatment of diabetes

Takeda Chemical Industries Ltd. · Granted Dec 11, 2001 · Expires Dec 6, 2021

US 6323226

Treatment of heart disease with cox-2 inhibitors

The Board of Regents of the University of Texas System · Granted Nov 27, 2001 · Expires Nov 22, 2021

US 6312694

Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System · Granted Nov 6, 2001 · Expires Nov 1, 2021

US 6309669

Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix

The United States of America as represented by the Secretary of the Army · Granted Oct 30, 2001 · Expires Oct 25, 2021

US 6306826

Treatment of heart failure with growth hormone

The Regents of the University of California · Granted Oct 23, 2001 · Expires Oct 18, 2021

US 6305380

Method for treatment of cancer and infectious disease

Maxim Pharmaceuticals, Inc. · Granted Oct 23, 2001 · Expires Oct 18, 2021

US 6300308

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System · Granted Oct 9, 2001 · Expires Oct 4, 2021

US 6299898

Methods and compositions for the treatment of wounds

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 9, 2001 · Expires Oct 4, 2021

US 6294574

Compounds and methods for the treatment of inflammatory and immune disorders

Cytomed, Inc. · Granted Sep 25, 2001 · Expires Sep 20, 2021

US 6291526

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Sep 18, 2001 · Expires Sep 13, 2021

US 6291501

Compounds and methods of use for treatment of neurogenic inflammation

The Regents of the University of California · Granted Sep 18, 2001 · Expires Sep 13, 2021

US 6291431

Methods and compositions for the treatment and prevention of Staphylococcal infections

The Regents of the University of California · Granted Sep 18, 2001 · Expires Sep 13, 2021

CN 1311670

Cholinergic agents in the treatment of presbyopia

ALLERGEN SALES INC [US] · Granted Sep 5, 2001 · Expires Aug 31, 2021

US 6270781

Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Maxim Pharmaceuticals, Inc. · Granted Aug 7, 2001 · Expires Aug 2, 2021